CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Harvard Bioscience, Inc. is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Harvard Bioscience, Inc.
84 October Hill Road
Phone: (508) 893-8999p:508 893-8999 HOLLISTON, MA  01746  United States Ticker: HBIOHBIO
Business Summary
Harvard Bioscience, Inc. is a developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bioproduction and preclinical testing for pharmaceutical and therapy development. Its products and services are sold globally to customers ranging from renowned academic institutions and government laboratories to pharmaceutical, biotechnology and contract research organizations (CROs). Its two product categories are cellular and molecular technology (CMT) and Preclinical. The CMT product family is primarily composed of products supporting research related to molecular, cellular, organ and organoid technologies. The Preclinical product family includes products that support the preclinical research and testing phase for drug development, and in particular, testing related to data collection and analysis for safety and regulatory compliance.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
12/31/202312/31/2023YesYes--Yes

Industries
SIC Code Description
3826 Laboratory analytical instruments
3841 Surgical and medical instruments and apparatus
3842 Orthopedic, prosthetic, and surgical appliances and supplies
8734 Testing laboratories

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, President, Chief Executive Officer James W.Green 64 7/8/2019 4/30/2015
Chief Financial Officer, Treasurer JenniferCote 52 6/19/2023 1/1/2023
Lead Independent Director BertrandLoy 58 7/8/2019 11/10/2014
3 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
BIOCHROM LIMITED UNIT 7, 3970 CAMBRIDGE RESEARCH BEACH DRIVE UK
MULTI CHANNEL SYSTEMS MCS GMBH ASPENHAUSTRASSE 21 REUTLINGEN DE
CARTESIAN TECHNOLOGIES 17851 SKY PARK CIRCLE, STE C IRVINE CA US
8 additional Subsidiary records available in full report.

Business Names
Business Name
Biochrom Limited
Biochrom US, Inc.
Biochrom Us, Inc.
15 additional Business Names available in full report.

General Information
Number of Employees: 391 (As of 12/31/2023)
Outstanding Shares: 43,421,251 (As of 3/20/2024)
Shareholders: 90
Stock Exchange: NASD
Federal Tax Id: 043306140
Fax Number: (508) 429-5732
Email Address: bioscience@harvardapparatus.com


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Sunday, April 28, 2024